RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 151 filers reported holding RA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 16.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $14,894,000 | -37.7% | 310,218 | -39.1% | 0.01% | -21.4% |
| Q4 2019 | $23,888,000 | +30.4% | 509,009 | -34.3% | 0.01% | +27.3% |
| Q3 2019 | $18,320,000 | +1442.1% | 774,645 | +1861.1% | 0.01% | +1000.0% |
| Q2 2019 | $1,188,000 | +99.3% | 39,500 | +48.5% | 0.00% | – |
| Q1 2019 | $596,000 | +29.6% | 26,600 | +5.1% | 0.00% | – |
| Q4 2018 | $460,000 | +46.0% | 25,300 | +45.4% | 0.00% | – |
| Q3 2018 | $315,000 | +115.8% | 17,400 | +18.4% | 0.00% | – |
| Q2 2018 | $146,000 | -25.1% | 14,700 | +41.3% | 0.00% | – |
| Q2 2017 | $195,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 2,031,562 | $17,268,000 | 2.42% |
| NEA Management Company, LLC | 3,493,636 | $29,696,000 | 1.23% |
| VHCP Management II, LLC | 544,612 | $4,629,000 | 1.11% |
| RA Capital Management | 1,351,808 | $11,490,000 | 0.96% |
| Rock Springs Capital Management LP | 600,000 | $5,100,000 | 0.23% |
| Rhenman & Partners Asset Management AB | 108,451 | $922,000 | 0.12% |
| Tekla Capital Management LLC | 356,237 | $3,028,000 | 0.12% |
| ELLINGTON MANAGEMENT GROUP LLC | 34,900 | $297,000 | 0.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 79,150 | $673,000 | 0.03% |
| Candriam S.C.A. | 151,000 | $1,284,000 | 0.02% |